Production (Stage)
E
PMV Pharmaceuticals, Inc. PMVP
$0.97 $0.022.11% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Total Cash And Short-Term Investments -18.97% -16.55% -9.45% 13.81% -13.73%
Total Receivables -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -15.90% 75.75% 133.06% 101.60% 22.40%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- 0.00% 0.00% 0.00%
Total Current Assets -19.24% -15.31% -7.64% 14.90% -13.21%

Total Current Assets -19.24% -15.31% -7.64% 14.90% -13.21%
Net Property, Plant & Equipment -92.48% -91.85% -4.29% -6.53% -6.16%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 30.22% 23.68% 34.44% 0.55% -42.04%
Total Assets -27.98% -24.14% -14.38% -1.93% -6.73%

Total Accounts Payable 318.28% 103.24% 22.94% 29.92% -51.58%
Total Accrued Expenses -43.77% -25.16% 13.49% -28.20% 20.90%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -58.64% -58.69% -- 6,294.44% 213.17%
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities -19.07% 2.43% 26.57% -0.54% 13.86%

Total Current Liabilities -19.07% 2.43% 26.57% -0.54% 13.86%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -93.89% -93.26% -5.32% -8.65% -7.99%
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities -56.61% -42.53% 9.28% -4.85% 1.74%

Common Stock & APIC 1.50% 1.72% 2.07% 9.13% 9.71%
Retained Earnings -18.72% -18.94% -17.49% -17.61% -25.02%
Treasury Stock & Other 165.12% -37.95% 215.49% 43.60% -11.21%
Total Common Equity -24.72% -21.98% -16.71% -1.60% -7.60%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity -24.72% -21.98% -16.71% -1.60% -7.60%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity -24.72% -21.98% -16.71% -1.60% -7.60%